JESSICA WHITAKER: Open Payments
NPI 1548570013 · RICHMOND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,748 in 53 payments from 19 companies in 2025. Trend: 2023 $361 · 2024 $529 · 2025 $1,748
Food & beverage: $954Travel & lodging: $794
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $794 |
| GlaxoSmithKline, LLC. | 9 | $161 |
| ABBVIE INC. | 7 | $140 |
| Dexcom, Inc. | 3 | $85 |
| Lilly USA, LLC | 5 | $80 |
| Corcept Therapeutics | 4 | $76 |
| Novo Nordisk Inc | 4 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $64 |
| Janssen Biotech, Inc. | 3 | $59 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
Products named: AMPLATZER TALISMAN, TRELEGY ELLIPTA, Dexcom G6 Transmitter, MOUNJARO, Korlym, TREMFYA, VRAYLAR, OFEV.
Industry payments across KY — which companies pay providers there.
